Infectious Disease Archives

Publication

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

Danielle Pillsbury2018 年 4 月 1 日

Blog

Using a Pharmacology to Payer Framework to Support Product Development

Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…

Certara2018 年 3 月 16 日

Publication

Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics

Danielle Pillsbury2018 年 3 月 1 日

Publication

Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial

Danielle Pillsbury2018 年 1 月 15 日

Publication

Model-informed Drug Development for Malaria Therapeutics

Danielle Pillsbury2018 年 1 月 6 日

Publication

Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics

Danielle Pillsbury2017 年 7 月 1 日

Publication

Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation

Danielle Pillsbury2017 年 4 月 1 日

Publication

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

Danielle Pillsbury2017 年 1 月 10 日

Publication

Limitations of MIC as Sole Metric of Pharmacodynamic Response Across the Range of Antimicrobial Susceptibilities within a Single Bacterial Species

The minimum inhibitory concentration (MIC) of an antimicrobial drug for a bacterial pathogen is used…

Danielle Pillsbury2016 年 12 月 1 日

Publication

Pharmacokinetics of Oral Terbinafine in Adult Horses

The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o.…

Danielle Pillsbury2016 年 11 月 24 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

传染性疾病

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

Using a Pharmacology to Payer Framework to Support Product Development

Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics

Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial

Model-informed Drug Development for Malaria Therapeutics

Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics

Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

Limitations of MIC as Sole Metric of Pharmacodynamic Response Across the Range of Antimicrobial Susceptibilities within a Single Bacterial Species

Pharmacokinetics of Oral Terbinafine in Adult Horses

订阅时事通讯

快捷链接

解决方案

联系我们